Jens Christian Jensenius
Founder at Helion Biotech ApS
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Per Bo Pedersen Fischer | M | - |
Helion Biotech ApS
 Helion Biotech ApS Pharmaceuticals: MajorHealth Technology Helion Biotech ApS develops and manufactures drugs. It develops a recombinant human protein from the innate immune system (MASP-2) for therapeutic use in cancer. The firm's MASP-2 protein is used to prevent or treat infectious episodes in MASP-2 deficient patients undergoing chemotherapy. The company was founded by Jeppe Vesti Christensen, Per Bo Pedersen Fischer, Jens Christian Jensenius and Steffen Thiel in 2008 and is headquartered in Lyngby, Denmark. | 16 years |
| Jesper Zeuthen | M | - |
University of Aarhus
| - |
| Claus Vastrup | M | 82 |
University of Aarhus
| - |
| Lars Henrik Fugger | M | 64 |
University of Aarhus
| 28 years |
| Michael Christiansen | M | 79 |
University of Aarhus
| - |
| Finn Skou Pedersen | M | - |
University of Aarhus
| - |
| Mogens Ryttergård Duch | M | - |
University of Aarhus
| - |
| Karl Møller Bek | M | - |
University of Aarhus
| - |
| Sara Fevre Kindberg | M | - |
University of Aarhus
| - |
| Karl Anker Jørgensen | M | 69 |
University of Aarhus
| - |
| Caroline Søeborg Ahlefeldt-Laurvig-Bille | F | - |
University of Aarhus
| 5 years |
| Børge Obel | M | 76 |
University of Aarhus
| 20 years |
| Jon Steen Petersen | M | 77 |
University of Aarhus
| - |
| Jeppe Vesti Christensen | M | - |
Helion Biotech ApS
Helion Biotech ApS Pharmaceuticals: MajorHealth Technology Helion Biotech ApS develops and manufactures drugs. It develops a recombinant human protein from the innate immune system (MASP-2) for therapeutic use in cancer. The firm's MASP-2 protein is used to prevent or treat infectious episodes in MASP-2 deficient patients undergoing chemotherapy. The company was founded by Jeppe Vesti Christensen, Per Bo Pedersen Fischer, Jens Christian Jensenius and Steffen Thiel in 2008 and is headquartered in Lyngby, Denmark. | 16 years |
| Steffen Thiel | M | 63 |
Helion Biotech ApS
Helion Biotech ApS Pharmaceuticals: MajorHealth Technology Helion Biotech ApS develops and manufactures drugs. It develops a recombinant human protein from the innate immune system (MASP-2) for therapeutic use in cancer. The firm's MASP-2 protein is used to prevent or treat infectious episodes in MASP-2 deficient patients undergoing chemotherapy. The company was founded by Jeppe Vesti Christensen, Per Bo Pedersen Fischer, Jens Christian Jensenius and Steffen Thiel in 2008 and is headquartered in Lyngby, Denmark. | 16 years |
| Anders Nykjaer | M | - |
University of Aarhus
| - |
| Henrik Kagenow | M | - |
University of Aarhus
| - |
| Peder Tuborgh | M | 61 |
University of Aarhus
| - |
| Brian Bech Nielsen | M | 66 |
University of Aarhus
| 36 years |
| Carsten Bjerg | M | 64 |
University of Aarhus
| - |
| Nina Smith | F | 68 |
University of Aarhus
| - |
| Connie Hedegaard Koksbang | F | 63 |
University of Aarhus
| 7 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Ole Bitsch-Jensen | M | - |
Helion Biotech ApS
Helion Biotech ApS Pharmaceuticals: MajorHealth Technology Helion Biotech ApS develops and manufactures drugs. It develops a recombinant human protein from the innate immune system (MASP-2) for therapeutic use in cancer. The firm's MASP-2 protein is used to prevent or treat infectious episodes in MASP-2 deficient patients undergoing chemotherapy. The company was founded by Jeppe Vesti Christensen, Per Bo Pedersen Fischer, Jens Christian Jensenius and Steffen Thiel in 2008 and is headquartered in Lyngby, Denmark. | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Denmark | 23 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jens Christian Jensenius
- Personal Network